Liposome composition
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- EISIA R&D MANAGEMENT CO LTD
- Publication Date
- 2012-03-07
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
technical field
[0001] The present invention relates to a new liposome composition containing eribulin or its pharmacologically acceptable salt. In addition, the present invention relates to a method for producing the liposome composition. Background technique
[0002] Liposomes are tiny closed vesicles that have an inner phase surrounded by one or more lipid bilayers, capable of retaining water-soluble substances in the inner phase and fat-soluble substances in the lipid layer. In a double layer. When encapsulating active compounds in liposomes and delivering them to target tissues, how to encapsulate active compounds in liposomes efficiently and how to ensure the stability of active compounds using liposomes becomes important. topic.
[0003] When encapsulating fat-soluble compounds in liposomes, high encapsulation efficiency can be achieved relatively easily, but compounds with very high membrane affinity except amphotericin B (the main drug of liposome drug AmBisome) ...